SCHEMBL14488023

SCHEMBL14488023

[CH]c1cc(S(=O)(=O)Nc2cccc(C)c2)ccc1Cl

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.58
▸ LMNA P02545 4/20 0.56
▸ ALDH1A1 P00352 3/20 0.56
▸ HTT P42858 2/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ GAA P10253 2/20 0.56
▸ MAPK1 P28482 1/20 0.55
▸ CYP19A1 P11511 1/20 0.53
▸ MEN1 O00255 4/20 0.52
▸ KMT2A Q03164 4/20 0.52
▸ XBP1 P17861 2/20 0.52
▸ PKM P14618 3/20 0.51
▸ TP53 P04637 2/20 0.50
▸ PGR P06401 1/20 0.50
▸ HPGD P15428 1/20 0.49
▸ CYP1A2 P05177 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26463794 0.82 CYP19A1 (0.78) MAPTLMNAALDH1A1HTTSMN1; SMN2
SCHEMBL15045213 0.81 KMT2A (0.71) MAPTLMNAALDH1A1HTTSMN1; SMN2
SCHEMBL11752812 0.81 VCAM1 (0.60) MAPTLMNAALDH1A1HTTSMN1; SMN2
SCHEMBL3701951 0.80 CA12 (0.71) MAPTLMNAALDH1A1HTTSMN1; SMN2
SCHEMBL15045384 0.79 KMT2A (0.60) MAPTLMNAALDH1A1MEN1KMT2A
SCHEMBL27181624 0.79 MAPT (0.80) MAPTLMNAALDH1A1SMN1; SMN2MAPK1
SCHEMBL30292407 0.79 MAPT (0.54) MAPTLMNAALDH1A1HTTSMN1; SMN2
SCHEMBL28577784 0.78 CYP19A1 (0.71) MAPTLMNAALDH1A1HTTSMN1; SMN2
SCHEMBL23057261 0.77 IDO1 (0.72) MAPTLMNAALDH1A1HTTSMN1; SMN2
SCHEMBL29561931 0.77 MEN1 (0.62) MAPTLMNAALDH1A1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2726459-A1 SULFAMOYLBENZAMIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST HBV INFECTION Institute for Hepatitis and Virus Research (US) 2014-05-07 — — EP claimed
WO-2013006394-A1 SULFAMOYLBENZAMIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST HBV INFECTION INSTITUTE FOR HEPATITIS AND VIRUS RESEARCH (US) 2013-01-10 — — WO claimed
Send feedback